Mix Of Scientists Research Articles

Staphylococcus Great Britain and Ireland 2023 (StaphGBI 2023) Conference Report.

Since 1997, Staphylococcus Great Britain and Ireland (StaphGBI) conferences have brought together the Staphylococcus research community in the UK and Ireland. The 12th StaphGBI conference, hosted by University of Galway 22-23 June 2023, was co-chaired by Dr Merve S. Zeden and Professor James P. O'Gara, supported by a local organizing committee of Chloe Hobbs-Tobin, Dr Rakesh Roy, Órla Burke and Aaron Nolan. Anchored by keynote speaker Professor Vinai Thomas, all other StaphGBI 2023 oral and post presentations were delivered by early career researchers. The conference attracted approximately 100 delegates, including 72 MRes/PhD students and postdoctoral fellows, 22 principal investigators and 4 exhibitors. The mix of scientists, clinicians and early career researchers stimulated excellent discussions on key issues and challenges in the Staphylococcus field. Staphylococcus aureus interactions with the host immune system, antimicrobial resistance (AMR) and new therapeutic approaches using antimicrobial peptides or metabolites, chronic wound and device-associated infections, and improving our understanding of staphylococcal genomics were common themes at StaphGBI 2023.

UNTOLD EFFECTS OF ENERGY FARMING

AFTER DECADES OF ETHANOL dreaming, farmers are seeing their vision come true. Corn prices are up, venture capital is flowing into the Farm Belt, and farmers and agricultural corporations are on a roll. There is money to be made from ethanol. If you don't believe that, you should have been in St. Louis in October. There in America's heartland, about 1,300 people filled the city's convention center for a two-day biofuels conference organized by the Department of Energy and the Department of Agriculture and titled An American Rural Renaissance. Speakers included top officials from both departments; the chief executive officers of DuPont, agricultural giant Archer Daniels Midland, and the National Corn Growers Association; farm-equipment makers, and other pro-ethanol corporate leaders, as well as a mix of scientists and entrepreneurs hoping to make a buck on renewable fuel. Opening and closing the conference was President George W. Bush himself. First, in a conference-opening video, ...

Advances in Targeted Therapies III, Nassau, Bahamas, 27 April-1 May 2001

This conference was the third in a series focusing on developments in the therapy of rheumatoid arthritis (RA) and other rheumatic conditions with biologicals; in many ways, it was perhaps the best one so far. One strength of the meeting was the mix of scientists from academia and from industry, and of workers in basic science as well as clinical investigators. The risks of inhibition of tumor necrosis factor (TNF) were covered in depth for the first time. A number of putative and actual new targets were presented. An updated consensus document on the use of TNF inhibitors will appear in the near future in the Annals of Rheumatic Diseases, authored by Dan Furst et al.

The President's message: How can G-AP flourish?

It is argued that if we are going to grow as an organization we must develop a plurality of competing sub-societies each with its standards of excellence. There is not enough room in one "tent," "one tree," "one ladder" for membership to receive recognition for the different modes of achievement and success. G-AP is not URSI or the US National Academy of Sciences (NAS) but a mix of scientists and engineers akin to the National Academy of Engineering and the NAS blended together with the EM radiation problems and goals of mankind as our common patrimony.